BCL2L1 and colorectal carcinoma: In colorectal carcinoma, IGF2BP3 has been shown to activate the MEK1/ERK signaling pathway and promote anti-apoptotic pathways through the stabilization of Bcl-2 and Bcl-xL transcripts [67,68].